Revolutionizing Machine Vision: Kyocera Unveils Triple Lens AI Depth Sensor for Advanced Object Recognition

New high-resolution camera detects fine and semi-transparent objects, paving the way for improved inspection processes, surgical and agricultural robots KYOTO, Japan–(BUSINESS WIRE)–Kyocera Corporation (President: Hideo Tanimoto; “Kyocera”)(TOKYO: 6971) has developed a Triple Lens AI-Based High-Resolution Depth Sensor for close imaging. The camera utilizes three lenses and proprietary AI to recognize semi-transparent, thin, and fine line-shaped … [Read more…]

Samsung Epis Holdings Announces Establishment of Epis NexLab, a New Subsidiary to Advance Next-Generation Biotechnology Platforms

INCHEON, Korea–(BUSINESS WIRE)–#EpisNexLab–Samsung Epis Holdings Co., Ltd. today announced the establishment of Epis NexLab Co., Ltd., a new subsidiary that will focus on the development of next-generation biotechnology platforms. Epis NexLab will focus on transforming highly scalable core technologies into platforms for the discovery of diverse new drug candidates, including license-out or joint development with … [Read more…]

Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX) (“Surmodics” or the “Company”), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that the United States District Court for the Northern District of Illinois (the “District Court”) has denied a request by the U.S. Federal Trade Commission (the … [Read more…]

Ontada Presents Framework for Accelerating Clinical Development with Real-World External Control Arms in Phase 2 Trials at ISPOR

The novel framework is designed to help accelerate clinical development through more efficient and informative early-stage trials BOSTON–(BUSINESS WIRE)–Ontada®, a leader in real-world oncology data and insights, will present new research findings in an oral presentation at the ISPOR Europe 2025 conference, being held this week in Glasgow, Scotland. ISPOR is the leading professional society … [Read more…]

U.S. Hemp Roundtable Strongly Opposes Proposed Senate Language to Recriminalize Hemp

WASHINGTON–(BUSINESS WIRE)–#HempHelps–The U.S. Hemp Roundtable issues the following statement regarding the proposed Senate language to recriminalize hemp products, condemning the harmful decision by Congress that threatens to eliminate America’s $28.4 billion hemp industry and jeopardizes more than 300,000 American jobs. If passed, this legislation would wipe out 95% of the industry, shuttering small businesses and … [Read more…]

Positive Development Applauds AACAP’s Call to Expand Autism Care Access and Recommendation That Payers Broaden Coverage to Include DRBI

New AACAP policy statement not only recommends payers offer coverage for evidence-based developmental relationship-based therapies, but also advises all physicians consider DRBI when recommending treatment for autism MCLEAN, Va.–(BUSINESS WIRE)–#Autism—The American Academy of Child and Adolescent Psychiatry (AACAP) has published a new policy statement recommending health insurers and physicians include a broader range of interventions, … [Read more…]

Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science

Multifaceted national initiative invites Americans to share stories of science’s impact and challenge misinformation ST. LOUIS–(BUSINESS WIRE)–Today, on World Science Day, Bayer is proud to launch its “Science Delivers” campaign, a nationwide initiative celebrating how science delivers answers, hope, and progress for all Americans—every day, in the moments that matter most. From the medicine that … [Read more…]

AHF’s Mobile Billboard Calls Out Gilead’s Greed at Pharma Summit

LOS ANGELES–(BUSINESS WIRE)–As the pharmaceutical industry gathers for the Global Pharma & Biotech Summit in London this week, AIDS Healthcare Foundation (AHF) is launching a mobile billboard that will circle the venue (Convene 22 Bishopsgate) on Nov. 11-12 to spotlight Gilead Sciences’ greed and refusal to make its breakthrough HIV prevention drug lenacapavir truly affordable … [Read more…]

Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL

The planned confirmatory Phase 3 trial, TELLOMAK 3, aims to demonstrate efficacy of lacutamab in patients with Sézary syndrome (SS) and Mycosis fungoides (MF), who failed at least one prior line of systemic therapy. The Company submitted the confirmatory Phase 3 TELLOMAK 3 protocol to the FDA, which completed its review with no further comments, … [Read more…]

Kaneka Expands Global Reach with i-ED COIL™ Launch in Europe

TOKYO–(BUSINESS WIRE)–Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) has begun sales of its i-ED COIL™, a brain aneurysm embolization coil (*1), in Europe as of October. The product obtained EC certification (*2) under an EU Medical Device Regulation (*3) in July and will be distributed primarily in Europe through Kaneka Medical Europe N.V. … [Read more…]